Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Holly L Thacker

Showing results (11-20 of 47) with videos related to

Pageof 5
Sort By:
Evidence-Based Medicine|January 11, 2007
Raloxifene produced both harms and benefits in postmenopausal women, with no reduction in cardiovascular disease riskHolly L Thacker
Cleveland Clinic Journal of Medicine|March 5, 2013
Sex, statins, and diabetesHolly L Thacker
Cleveland Clinic Journal of Medicine|November 9, 2016
To the Editor: Menopausal hormone therapyHolly L Thacker
Cleveland Clinic Journal of Medicine|December 3, 2011
Bioidentical hormone therapy: clarifying the misconceptionsLynn Pattimakiel, Holly L Thacker
Women'S Health (London, England)|March 8, 2014
Paroxetine: a first for selective serotonin reuptake inhibitors - a new use: approved for vasomotor symptoms in postmenopausal womenLauren Weber, Holly L Thacker
Cleveland Clinic Journal of Medicine|March 3, 2012
Update on contraceptive options: a case-based discussionKristi Tough, Holly L Thacker
Cleveland Clinic Journal of Medicine|February 1, 2006
In rebuttal: Osteopenia is a useful diagnosisHolly L Thacker, Bradford Richmond
Cleveland Clinic Journal of Medicine|August 24, 2004
Treatment options for menopausal hot flashesAndrea Sikon, Holly L Thacker
Cleveland Clinic Journal of Medicine|July 28, 2005
Overactive bladderHolly L Thacker, Marie Paraiso
Geriatrics|July 24, 2002
Prevention for the older woman. A practical guide to managing cardiovascular diseaseBarbara J Messinger-Rapport, Holly L Thacker
Pageof 5

Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
Evidence-Based Medicine|January 11, 2007
Raloxifene produced both harms and benefits in postmenopausal women, with no reduction in cardiovascular disease riskHolly L Thacker
Cleveland Clinic Journal of Medicine|March 5, 2013
Sex, statins, and diabetesHolly L Thacker
Cleveland Clinic Journal of Medicine|November 9, 2016
To the Editor: Menopausal hormone therapyHolly L Thacker
Cleveland Clinic Journal of Medicine|December 3, 2011
Bioidentical hormone therapy: clarifying the misconceptionsLynn Pattimakiel, Holly L Thacker
Women'S Health (London, England)|March 8, 2014
Paroxetine: a first for selective serotonin reuptake inhibitors - a new use: approved for vasomotor symptoms in postmenopausal womenLauren Weber, Holly L Thacker
Cleveland Clinic Journal of Medicine|March 3, 2012
Update on contraceptive options: a case-based discussionKristi Tough, Holly L Thacker
Cleveland Clinic Journal of Medicine|February 1, 2006
In rebuttal: Osteopenia is a useful diagnosisHolly L Thacker, Bradford Richmond
Cleveland Clinic Journal of Medicine|August 24, 2004
Treatment options for menopausal hot flashesAndrea Sikon, Holly L Thacker
Cleveland Clinic Journal of Medicine|July 28, 2005
Overactive bladderHolly L Thacker, Marie Paraiso
Geriatrics|July 24, 2002
Prevention for the older woman. A practical guide to managing cardiovascular diseaseBarbara J Messinger-Rapport, Holly L Thacker
Pageof 5